Your browser doesn't support javascript.
loading
Structure-activity relationship studies on the inhibition of the bacterial translation of novel Odilorhabdins analogues.
Loza, Einars; Sarciaux, Matthieu; Ikaunieks, Martins; Katkevics, Martins; Kukosha, Tatyana; Trufilkina, Nadezhda; Ryabova, Victoria; Shubin, Kirill; Pantel, Lucile; Serri, Marine; Huseby, Douglas L; Cao, Sha; Yadav, Kavita; Hjort, Karin; Hughes, Diarmaid; Gualtieri, Maxime; Suna, Edgars; Racine, Emilie.
Afiliación
  • Loza E; Latvian Institute of Organic Synthesis, Aizkraukles 21, LV-1006 Riga, Latvia.
  • Sarciaux M; Nosopharm, 110 allée Charles Babbage, Espace Innovation 2, 30000 Nîmes, France.
  • Ikaunieks M; Latvian Institute of Organic Synthesis, Aizkraukles 21, LV-1006 Riga, Latvia.
  • Katkevics M; Latvian Institute of Organic Synthesis, Aizkraukles 21, LV-1006 Riga, Latvia.
  • Kukosha T; Latvian Institute of Organic Synthesis, Aizkraukles 21, LV-1006 Riga, Latvia.
  • Trufilkina N; Latvian Institute of Organic Synthesis, Aizkraukles 21, LV-1006 Riga, Latvia.
  • Ryabova V; Latvian Institute of Organic Synthesis, Aizkraukles 21, LV-1006 Riga, Latvia.
  • Shubin K; Latvian Institute of Organic Synthesis, Aizkraukles 21, LV-1006 Riga, Latvia.
  • Pantel L; Nosopharm, 110 allée Charles Babbage, Espace Innovation 2, 30000 Nîmes, France.
  • Serri M; Nosopharm, 110 allée Charles Babbage, Espace Innovation 2, 30000 Nîmes, France.
  • Huseby DL; Department of Medical Biochemistry and Microbiology, Biomedical Center, Uppsala University, Uppsala, Sweden.
  • Cao S; Department of Medical Biochemistry and Microbiology, Biomedical Center, Uppsala University, Uppsala, Sweden.
  • Yadav K; Department of Medical Biochemistry and Microbiology, Biomedical Center, Uppsala University, Uppsala, Sweden.
  • Hjort K; Department of Medical Biochemistry and Microbiology, Biomedical Center, Uppsala University, Uppsala, Sweden.
  • Hughes D; Department of Medical Biochemistry and Microbiology, Biomedical Center, Uppsala University, Uppsala, Sweden.
  • Gualtieri M; Nosopharm, 110 allée Charles Babbage, Espace Innovation 2, 30000 Nîmes, France.
  • Suna E; Latvian Institute of Organic Synthesis, Aizkraukles 21, LV-1006 Riga, Latvia. Electronic address: edgars@osi.lv.
  • Racine E; Nosopharm, 110 allée Charles Babbage, Espace Innovation 2, 30000 Nîmes, France. Electronic address: e.racine@nosopharm.com.
Bioorg Med Chem ; 28(11): 115469, 2020 06 01.
Article en En | MEDLINE | ID: mdl-32279921
A structure-activity relationship (SAR) study of NOSO-95179, a nonapeptide from the Odilorhabdin class of antibacterials, was performed by systematic variations of amino acids in positions 2 and 5 of the peptide. A series of non-proteinogenic amino acids was synthesized in high enantiomeric purity from Williams' chiral diphenyloxazinone by highly diastereoselective alkylation or by aldol-type reaction. NOSO-95179 analogues for SAR studies were prepared using solid-phase peptide synthesis. Inhibition of bacterial translation by each of the synthesized Odilorhabdin analogues was measured using an in vitro test. For the most efficient analogues, antibacterial efficacy was measured against two wild-type Enterobacteriaceae (Escherichia coli and Klebsiella pneumoniae) and against an efflux defective E. coli strain (ΔtolC) to evaluate the impact of efflux on the antibacterial activity.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Oligopéptidos / Escherichia coli / Klebsiella pneumoniae / Antibacterianos Idioma: En Revista: Bioorg Med Chem Asunto de la revista: BIOQUIMICA / QUIMICA Año: 2020 Tipo del documento: Article País de afiliación: Letonia Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Oligopéptidos / Escherichia coli / Klebsiella pneumoniae / Antibacterianos Idioma: En Revista: Bioorg Med Chem Asunto de la revista: BIOQUIMICA / QUIMICA Año: 2020 Tipo del documento: Article País de afiliación: Letonia Pais de publicación: Reino Unido